Melatonin as a Potential Regulator of Oxidative Stress, and Neuroinflammation: Mechanisms and Implications for the Management of Brain Injury-Induced Neurodegeneration

References

• Kaur P, Sharma S. Recent advances in pathophysiology of traumatic brain injury. Curr Neuropharmacol. 2018;16(8):1224–1238. doi:10.2174/1570159X15666170613083606
   PubMed Web of Science ®Google Scholar
• McKee AC, Daneshvar DH. The neuropathology of traumatic brain injury. Handb Clin Neurol. 2015;127:45–66.
   PubMedGoogle Scholar
• Ahmed S, Venigalla H, Mekala HM, Dar S, Hassan M, Ayub S. Traumatic brain injury and neuropsychiatric complications. Indian J Psychol Med. 2017;39(2):114–121. doi:10.4103/0253-7176.203129
   PubMedGoogle Scholar
• Maas AIR, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987–1048. doi:10.1016/S1474-4422(17)30371-X
   PubMed Web of Science ®Google Scholar
• Dams-O’Connor K, Guetta G, Hahn-Ketter AE, Fedor A. Traumatic brain injury as a risk factor for Alzheimer’s disease: current knowledge and future directions. Neurodegener Dis Manag. 2016;6(5):417–429. doi:10.2217/nmt-2016-0017
   PubMed Web of Science ®Google Scholar
• Gardner AJ, Zafonte R. Neuroepidemiology of traumatic brain injury. Handb Clin Neurol. 2016;138:207–223.
   PubMedGoogle Scholar
• Jiang JY, Gao GY, Feng JF, et al. Traumatic brain injury in China. Lancet Neurol. 2019;18(3):286–295. doi:10.1016/S1474-4422(18)30469-1
   PubMed Web of Science ®Google Scholar
• Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528. doi:10.3389/fncel.2019.00528
   PubMed Web of Science ®Google Scholar
• Osier N, McGreevy E, Pham L, et al. Melatonin as a therapy for traumatic brain injury: a review of published evidence. Int J Mol Sci. 2018;19(5):1539. doi:10.3390/ijms19051539
   PubMed Web of Science ®Google Scholar
• Rehman SU, Ikram M, Ullah N, et al. Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK/CREB signaling. Cells. 2019;8(7):760. doi:10.3390/cells8070760
   PubMed Web of Science ®Google Scholar
• Gulpinar O, Guclu AG. How to write a review article? Turk J Urol. 2013;39(Suppl 1):44–48. doi:10.5152/tud.2013.054
   PubMedGoogle Scholar
• Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–84. doi:10.1016/S0140-6736(74)91639-0
   PubMed Web of Science ®Google Scholar
• Black KL, Hanks RA, Wood DL, et al. Blunt versus penetrating violent traumatic brain injury: frequency and factors associated with secondary conditions and complications. J Head Trauma Rehabil. 2002;17(6):489–496. doi:10.1097/00001199-200212000-00001
   PubMed Web of Science ®Google Scholar
• Warden D. Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil. 2006;21(5):398–402. doi:10.1097/00001199-200609000-00004
   PubMed Web of Science ®Google Scholar
• Ling GS, Ecklund JM. Traumatic brain injury in modern war. Curr Opin Anaesthesiol. 2011;24(2):124–130. doi:10.1097/ACO.0b013e32834458da
   PubMed Web of Science ®Google Scholar
• Hemphill MA, Dauth S, Yu CJ, Dabiri BE, Parker KK. Traumatic brain injury and the neuronal microenvironment: a potential role for neuropathological mechanotransduction. Neuron. 2015;85(6):1177–1192. doi:10.1016/j.neuron.2015.02.041
   PubMed Web of Science ®Google Scholar
• Ray SK, Dixon CE, Banik NL. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol. 2002;17(4):1137–1152. doi:10.14670/HH-17.1137
   PubMed Web of Science ®Google Scholar
• Kumar Sahel D, Kaira M, Raj K, Sharma S, Singh S. Mitochondrial dysfunctioning and neuroinflammation: recent highlights on the possible mechanisms involved in traumatic brain injury. Neurosci Lett. 2019;710:134347. doi:10.1016/j.neulet.2019.134347
   PubMed Web of Science ®Google Scholar
• Bullock R, Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J Neurotrauma. 1992;9(Suppl 2):S443–462.
   PubMedGoogle Scholar
• Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61(6):657–668. doi:10.1007/s00018-003-3319-x
   PubMed Web of Science ®Google Scholar
• Tavazzi B, Signoretti S, Lazzarino G, et al. Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery. 2005;56(3):582–589. doi:10.1227/01.NEU.0000156715.04900.E6
   PubMed Web of Science ®Google Scholar
• Battelli MG, Polito L, Bortolotti M, Bolognesi A. Xanthine oxidoreductase-derived reactive species: physiological and pathological effects. Oxid Med Cell Longev. 2016;2016:3527579. doi:10.1155/2016/3527579
   PubMed Web of Science ®Google Scholar
• Collin F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int J Mol Sci. 2019;20(10):2407. doi:10.3390/ijms20102407
   PubMed Web of Science ®Google Scholar
• Ikram M, Ullah R, Khan A, Kim MO. Ongoing research on the role of gintonin in the management of neurodegenerative disorders. Cells. 2020;9(6):1464. doi:10.3390/cells9061464
   PubMed Web of Science ®Google Scholar
• Liu XF, Zhou DD, Xie T, et al. The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases. Int J Biol Sci. 2018;14(9):1090–1098. doi:10.7150/ijbs.25996
   PubMed Web of Science ®Google Scholar
• Zhou T, Zong R, Zhang Z, et al. SERPINA3K protects against oxidative stress via modulating ROS generation/degradation and KEAP1-NRF2 pathway in the corneal epithelium. Invest Ophthalmol Vis Sci. 2012;53(8):5033–5043. doi:10.1167/iovs.12-9729
   PubMed Web of Science ®Google Scholar
• David JA, Rifkin WJ, Rabbani PS, Ceradini DJ. The Nrf2/Keap1/ARE pathway and oxidative stress as a therapeutic target in type II diabetes mellitus. J Diabetes Res. 2017;2017:4826724. doi:10.1155/2017/4826724
   PubMed Web of Science ®Google Scholar
• Wang CC, Wee HY, Hu CY, Chio CC, Kuo JR. The effects of memantine on glutamic receptor-associated nitrosative stress in a traumatic brain injury rat model. World Neurosurg. 2018;112:e719–e731. doi:10.1016/j.wneu.2018.01.140
   PubMed Web of Science ®Google Scholar
• Ikram M, Park TJ, Ali T, Kim MO. Antioxidant and neuroprotective effects of caffeine against Alzheimer’s and Parkinson’s disease: insight into the role of Nrf-2 and A2AR signaling. Antioxidants (Basel). 2020;9(9):902.
   PubMedGoogle Scholar
• Fresta CG, Chakraborty A, Wijesinghe MB, et al. Non-toxic engineered carbon nanodiamond concentrations induce oxidative/nitrosative stress, imbalance of energy metabolism, and mitochondrial dysfunction in microglial and alveolar basal epithelial cells. Cell Death Dis. 2018;9(2):245. doi:10.1038/s41419-018-0280-z
   PubMed Web of Science ®Google Scholar
• Bains M, Hall ED. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta. 2012;1822(5):675–684. doi:10.1016/j.bbadis.2011.10.017
   PubMed Web of Science ®Google Scholar
• Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res. 1998;53(1):66–77. doi:10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Castilho RF, Kowaltowski AJ, Meinicke AR, Bechara EJ, Vercesi AE. Permeabilization of the inner mitochondrial membrane by Ca2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radic Biol Med. 1995;18(3):479–486. doi:10.1016/0891-5849(94)00166-H
   PubMed Web of Science ®Google Scholar
• Lotocki G, de Rivero Vaccari JP, Perez ER, et al. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma. 2009;26(7):1123–1134. doi:10.1089/neu.2008.0802
   PubMed Web of Science ®Google Scholar
• Buttram SD, Wisniewski SR, Jackson EK, et al. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J Neurotrauma. 2007;24(11):1707–1717. doi:10.1089/neu.2007.0349
   PubMed Web of Science ®Google Scholar
• Frugier T, Morganti-Kossmann MC, O’Reilly D, McLean CA. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 2010;27(3):497–507. doi:10.1089/neu.2009.1120
   PubMed Web of Science ®Google Scholar
• Faden AI, Wu J, Stoica BA, Loane DJ. Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. Br J Pharmacol. 2016;173(4):681–691. doi:10.1111/bph.13179
   PubMed Web of Science ®Google Scholar
• Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19(8):312–318. doi:10.1016/0166-2236(96)10049-7
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Strowig T, Flavell RA. Inflammasomes: far beyond inflammation. Nat Immunol. 2012;13(4):321–324. doi:10.1038/ni.2257
   PubMed Web of Science ®Google Scholar
• O’Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation. 2020;17(1):104. doi:10.1186/s12974-020-01778-5
   PubMed Web of Science ®Google Scholar
• Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care management. Br J Anaesth. 2007;99(1):32–42. doi:10.1093/bja/aem139
   PubMed Web of Science ®Google Scholar
• Pontifex MG, Malik M, Connell E, Muller M, Vauzour D. Citrus polyphenols in brain health and disease: current perspectives. Front Neurosci. 2021;15:640648. doi:10.3389/fnins.2021.640648
   PubMed Web of Science ®Google Scholar
• Scott G, Zetterberg H, Jolly A, et al. Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration. Brain. 2018;141(2):459–471. doi:10.1093/brain/awx339
   PubMed Web of Science ®Google Scholar
• Thompson HJ, Bakshi A. Methylprednisolone was associated with an increase in death after head injury. Evid Based Nurs. 2005;8(2):51. doi:10.1136/ebn.8.2.51
   PubMedGoogle Scholar
• Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED. A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J Neurotrauma. 2010;27(12):2233–2243. doi:10.1089/neu.2010.1474
   PubMed Web of Science ®Google Scholar
• Buki A, Farkas O, Doczi T, Povlishock JT. Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma. 2003;20(3):261–268. doi:10.1089/089771503321532842
   PubMed Web of Science ®Google Scholar
• Campolo M, Casili G, Lanza M, et al. The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury. J Cell Mol Med. 2021;25(16):7855–7866. doi:10.1111/jcmm.16702
   PubMed Web of Science ®Google Scholar
• Samii A, Badie H, Fu K, Luther RR, Hovda DA. Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury. J Neurotrauma. 1999;16(10):879–892. doi:10.1089/neu.1999.16.879
   PubMed Web of Science ®Google Scholar
• Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005;1:CD000196.
   Google Scholar
• Kertmen H, Gurer B, Yilmaz ER, et al. Antioxidant and antiapoptotic effects of darbepoetin-alpha against traumatic brain injury in rats. Arch Med Sci. 2015;11(5):1119–1128. doi:10.5114/aoms.2015.54869
   PubMed Web of Science ®Google Scholar
• O’Neil DA, Nicholas MA, Lajud N, Kline AE, Bondi CO. Preclinical models of traumatic brain injury: emerging role of glutamate in the pathophysiology of depression. Front Pharmacol. 2018;9:579. doi:10.3389/fphar.2018.00579
   PubMed Web of Science ®Google Scholar
• Kim B, Haque A, Arnaud FG, et al. Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury. J Emerg Trauma Shock. 2014;7(2):102–111. doi:10.4103/0974-2700.130880
   PubMedGoogle Scholar
• Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83(6):401–420. doi:10.1097/01.PHM.0000128789.75375.D3
   PubMed Web of Science ®Google Scholar
• Reppert SM, Weaver DR, Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci. 1996;17(3):100–102. doi:10.1016/0165-6147(96)10005-5
   PubMed Web of Science ®Google Scholar
• Costa EJ, Lopes RH, Lamy-Freund MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res. 1995;19(3):123–126. doi:10.1111/j.1600-079X.1995.tb00180.x
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002;2(2):181–197. doi:10.2174/1568026023394443
   PubMedGoogle Scholar
• Ikram M, Jo MG, Park TJ, et al. Oral administration of gintonin protects the brains of mice against abeta-induced Alzheimer disease pathology: antioxidant and anti-inflammatory effects. Oxid Med Cell Longev. 2021;2021:6635552. doi:10.1155/2021/6635552
   PubMed Web of Science ®Google Scholar
• Khan A, Park TJ, Ikram M, et al. Antioxidative and anti-inflammatory effects of Kojic acid in abeta-induced mouse model of Alzheimer’s disease. Mol Neurobiol. 2021;58(10):5127–5140. doi:10.1007/s12035-021-02460-4
   PubMed Web of Science ®Google Scholar
• Du G, Zhao Z, Chen Y, et al. Quercetin protects rat cortical neurons against traumatic brain injury. Mol Med Rep. 2018;17(6):7859–7865. doi:10.3892/mmr.2018.8801
   PubMed Web of Science ®Google Scholar
• Tsai MC, Chen WJ, Tsai MS, Ching CH, Chuang JI. Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats. J Pineal Res. 2011;51(2):233–245. doi:10.1111/j.1600-079X.2011.00885.x
   PubMed Web of Science ®Google Scholar
• Wang Z, Ma C, Meng CJ, et al. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. J Pineal Res. 2012;53(2):129–137. doi:10.1111/j.1600-079X.2012.00978.x
   PubMed Web of Science ®Google Scholar
• Ding K, Wang H, Xu J, et al. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radic Biol Med. 2014;73:1–11. doi:10.1016/j.freeradbiomed.2014.04.031
   PubMed Web of Science ®Google Scholar
• Beni SM, Kohen R, Reiter RJ, Tan DX, Shohami E. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J. 2004;18(1):149–151. doi:10.1096/fj.03-0323fje
   PubMed Web of Science ®Google Scholar
• Brooks GA, Martin NA. Cerebral metabolism following traumatic brain injury: new discoveries with implications for treatment. Front Neurosci. 2014;8:408.
   PubMed Web of Science ®Google Scholar
• Hovda DA, Yoshino A, Kawamata T, Katayama Y, Becker DP. Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res. 1991;567(1):1–10. doi:10.1016/0006-8993(91)91429-5
   PubMed Web of Science ®Google Scholar
• Yoshino A, Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res. 1991;561(1):106–119. doi:10.1016/0006-8993(91)90755-K
   PubMed Web of Science ®Google Scholar
• Dietrich WD, Alonso O, Busto R, Ginsberg MD. Widespread metabolic depression and reduced somatosensory circuit activation following traumatic brain injury in rats. J Neurotrauma. 1994;11(6):629–640. doi:10.1089/neu.1994.11.629
   PubMed Web of Science ®Google Scholar
• Prins ML, Fujima LS, Hovda DA. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res. 2005;82(3):413–420. doi:10.1002/jnr.20633
   PubMed Web of Science ®Google Scholar
• Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG. Fasting is neuroprotective following traumatic brain injury. J Neurosci Res. 2008;86(8):1812–1822. doi:10.1002/jnr.21628
   PubMed Web of Science ®Google Scholar
• Hill JL, Kobori N, Zhao J, et al. Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome. J Neurochem. 2016;139(1):106–119. doi:10.1111/jnc.13726
   PubMed Web of Science ®Google Scholar
• Ozdemir D, Uysal N, Gonenc S, et al. Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res. 2005;54(6):631–637.
   PubMed Web of Science ®Google Scholar
• Lee S, Jadhav V, Ayer R, et al. The antioxidant effects of melatonin in surgical brain injury in rats. Acta Neurochir Suppl. 2008;102:367–371.
   PubMedGoogle Scholar
• Stazi M, Negro S, Megighian A, et al. Melatonin promotes regeneration of injured motor axons via MT1 receptors. J Pineal Res. 2021;70:e12695.
   PubMed Web of Science ®Google Scholar
• Wu H, Shao A, Zhao M, et al. Melatonin attenuates neuronal apoptosis through up-regulation of K(+) -Cl(-) cotransporter KCC2 expression following traumatic brain injury in rats. J Pineal Res. 2016;61(2):241–250. doi:10.1111/jpi.12344
   PubMed Web of Science ®Google Scholar
• Senol N, Naziroglu M. Melatonin reduces traumatic brain injury-induced oxidative stress in the cerebral cortex and blood of rats. Neural Regen Res. 2014;9(11):1112–1116. doi:10.4103/1673-5374.135312
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42. doi:10.1016/j.cell.2007.12.018
   PubMed Web of Science ®Google Scholar
• Lipinski MM, Wu J, Faden AI, Sarkar C. Function and mechanisms of autophagy in brain and spinal cord trauma. Antioxid Redox Signal. 2015;23(6):565–577. doi:10.1089/ars.2015.6306
   PubMed Web of Science ®Google Scholar
• Lin C, Chao H, Li Z, et al. Melatonin attenuates traumatic brain injury-induced inflammation: a possible role for mitophagy. J Pineal Res. 2016;61(2):177–186. doi:10.1111/jpi.12337
   PubMed Web of Science ®Google Scholar
• Ding K, Xu J, Wang H, Zhang L, Wu Y, Li T. Melatonin protects the brain from apoptosis by enhancement of autophagy after traumatic brain injury in mice. Neurochem Int. 2015;91:46–54. doi:10.1016/j.neuint.2015.10.008
   PubMed Web of Science ®Google Scholar
• Kuwar R, Rolfe A, Di L, et al. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflammation. 2019;16(1):81. doi:10.1186/s12974-019-1471-y
   PubMedGoogle Scholar
• Cao S, Shrestha S, Li J, et al. Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep. 2017;7(1):2417. doi:10.1038/s41598-017-02679-z
   PubMedGoogle Scholar
• Dehghan F, Shahrokhi N, Khaksari M, et al. Does the administration of melatonin during post-traumatic brain injury affect cytokine levels? Inflammopharmacology. 2018;26(4):1017–1023. doi:10.1007/s10787-017-0417-1
   PubMed Web of Science ®Google Scholar
• Grivas TB, Savvidou OD. Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis. Scoliosis. 2007;2:6. doi:10.1186/1748-7161-2-6
   PubMedGoogle Scholar
• Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med. 2018;16(1):8. doi:10.1186/s12916-017-0995-1
   PubMedGoogle Scholar
• Grima NA, Ponsford JL, St Hilaire MA, Mansfield D, Rajaratnam SM. Circadian melatonin rhythm following traumatic brain injury. Neurorehabil Neural Repair. 2016;30(10):972–977.
   PubMed Web of Science ®Google Scholar
• Seifman MA, Gomes K, Nguyen PN, et al. Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions. Front Neurol. 2014;5:237. doi:10.3389/fneur.2014.00237
   PubMed Web of Science ®Google Scholar
• Li SS, Xie LL, Li ZZ, Fan YJ, Qi MM, Xi YG. Androgen is responsible for enhanced susceptibility of melatonin against traumatic brain injury in females. Neurosci Lett. 2021;752:135842. doi:10.1016/j.neulet.2021.135842
   PubMed Web of Science ®Google Scholar